With careful planning and effort, your businesses can capitalize on pharmaceutical and adult-use/medical cannabis markets simultaneously. A growing number of companies are looking at “dual tracking” their businesses globally to tap into these seemingly disparate markets. Hear from an industry executive whose company is pursuing such a strategy at the global level.
You’ll get insights on:
- The differences between medical cannabis and pharmaceutical drugs – and how this dichotomy evolved.
- How your company may pursue a dual track business strategy on a global level.
- The challenges of creating a global pharma business while also focusing on U.S. domestic medical/adult-use cannabis.
- What countries are ripe for this dual track approach, including the pursuit of clinical trials.